Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
People
Allergan Opens R&D Center In New Jersey
by Michael McCoy
September 10, 2012
| A version of this story appeared in
Volume 90, Issue 37
Allergan has opened an R&D center in Bridgewater, N.J., that it says will eventually house several hundred employees. The California-based health care firm says the center will focus on clinical development. Allergan’s decision to open the lab contrasts with lab closings in New Jersey by drug companies such as Roche, Merck & Co., and Pfizer. Allergan CEO David E. I. Pyott told guests who gathered for an opening event that his firm expects to spend more than $1 billion on R&D in 2013.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X